Fundraising FoxSDIC Venture Capital — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Ractigenractigen.comin𝕏Jan 2022 · $30M✓ verified
Ractigen Therapeutics develops proprietary RNA delivery platforms for oligonucleotide therapeutics, enabling treatment of previously unreachable tissues and organs in the CNS and beyond the liver.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSuzhou, CN
Dr. Long-Cheng Li(CEO and Founder)Dr. Moorim Kang(Chief Technology Officer)
Co-investorsEisai Innovation, Inc.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.